Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

LSR reported for 3 months of 2025 by RAS

4/21/25 LSRG

NEFAZ reports for 3 months of 2025 under RAS

4/21/25 NFAZ

Nornickel's production performance continued to decline

4/21/25 GMKN

Shareholders of NOVATEK approved dividends for 2024

4/21/25 NVTK

Delimobile united business units under a single brand

4/21/25 DELI

T-Bank reported for March 2025

4/21/25 T

Yuzhuralzoloto reported for 2024 by IFRS

4/21/25 UGLD

Europlan's new business in Q1 decreased by 61%

4/21/25 LEAS

MTS reported for 2024 by RAS

4/18/25 MTSS

Shareholders of LSR Group approved dividends for 2024

4/18/25 LSRG